
PanIN lesions can lead to invasive ductal adenocarcinoma, which affects nearly half a million people globally

Pancreatic cancer accounts for approximately 3.3% of all new cancer cases

More than 90% of patients with locally advanced disease are not eligible for surgery

The investigational treatment regimen met its primary endpoint of overall survival